pharmacia

Pharmacia was a multinational pharmaceutical company with roots in Sweden and the United States. It existed in the late 20th and early 21st centuries as the result of two major mergers that reshaped the global pharmaceutical industry.

In 1995, the Swedish company Pharmacia AB merged with Upjohn, an American pharmaceutical company, to form Pharmacia & Upjohn. The new entity expanded its global footprint and diversified its drug portfolio, operating in multiple therapeutic areas and markets around the world.

In 2000, Pharmacia & Upjohn merged with Monsanto Company to form Pharmacia Corporation. This created a large, diversified health care and life sciences company with both pharmaceutical and agricultural components, continuing cross-border research and development and a broad product pipeline.

In 2003, Pfizer announced the acquisition of Pharmacia Corporation in a deal valued at about $60 billion. The acquisition was completed later that year, and Pharmacia became part of Pfizer. Following the merger, the Pharmacia brand was gradually retired as its products, employees, and operations were integrated into Pfizer’s organizational structure.

Legacy and impact: The Pharmacia lineage contributed to the global pharmaceutical landscape through its post-merger products and research capabilities. After the completion of the Pfizer acquisition, the Pharmacia name largely disappeared from corporate branding, with former Pharmacia assets incorporated into Pfizer’s operations.